Simply Better Brands Corp.

Simply Better Brands Corp. manufactures and sells hemp-based cannabidiol related products in the United States. The company offers tinctures, topicals, capsules, gummies, pet tinctures and treats, bath bombs, pet wellness products, and skincare products comprising caffeine eye cream, retinol night cream, charcoal peel-off masks, moisturizers, serums, toner, cleanser, and acne patches. It also provides nutritious bars. The company offers its products under the PureKana, Tru Brand, BudaPets, and No BS brands. Simply Better Brands Corp. sells its products through its own e-commerce platforms, and brick and mortar retailers. The company was formerly known as PureK Holdings Corp. and changed its name to Simply Better Brands Corp. in May 2021. The company was founded in 2017 and is headquartered in Vancouver, Canada. Simply Better Brands Corp. is a subsidiary of Heavenly Rx Ltd.

Simply Better Brands Corp. trades as PKANF on OTC. The company is classified in Healthcare / Drug Manufacturers - Specialty & Generic and reports in USD.

The current profile places the business in Drug Manufacturers - Specialty & Generic. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $65.41M of revenue and -$12.35M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Simply Better Brands Corp. can be compared against peers such as RIV Capital Inc., The Hempshire Group, Inc., MGC Pharmaceuticals Limited, Noxopharm Limited, Lifeist Wellness Inc., Poxel S.A..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $14.81M, beta of 3.33, and return on equity of -98.1%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

PKANF currently shows total debt of $19.15M and beta of 3.33. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.simplybetterbrands.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.